NCT04876976

Brief Summary

cyanoacrylate has an impact that may aid in the successful repair of urethra-cutaneous fistula (UCF) that occur after hypospadias surgical repair

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for phase_2

Timeline
Completed

Started Jan 2017

Typical duration for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2017

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2020

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

April 29, 2021

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 7, 2021

Completed
Last Updated

May 7, 2021

Status Verified

May 1, 2021

Enrollment Period

3 years

First QC Date

April 29, 2021

Last Update Submit

May 3, 2021

Conditions

Keywords

Isoamyl 2-cyanoacrylateurethrocutaneous fistulafistula repairhypospadias

Outcome Measures

Primary Outcomes (1)

  • successful repair of the fistula

    surgical outcome regarding the repair of urethro-cutaneous fistula, whether adequate healing occurred or recurrence is present

    6 months after surgery

Secondary Outcomes (1)

  • postoperative complications

    6 months after surgery

Study Arms (2)

Cases of group (I) cyanoacrylate glue

EXPERIMENTAL

Cases of group (I) underwent multilayered closure using dartos facial flap and cyanoacrylate glue as an interposition layer.

Drug: Cyanoacrylate, Isobutyl

Cases of the control group (II) , classic repair

ACTIVE COMPARATOR

Cases of the control group (II) underwent the same procedure without using cyanoacrylate.

Procedure: Classic surgical repair

Interventions

using cyanoacrylate in the surgical repair of urethro-cutaneous fistula

Cases of group (I) cyanoacrylate glue

classical repair of urethro-cutaneous fistula without the use of cyanoacryalte

Cases of the control group (II) , classic repair

Eligibility Criteria

Sexmale(Gender-based eligibility)
Gender Eligibility DetailsHypospadias is a male urethral congenital anomaly
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with Urethro-cutaneous fistula regardless of their age were included in our study.

You may not qualify if:

  • Patients with fistula size more than 5 mm
  • multiple fistulas
  • uncorrected obstruction distal to the fistula
  • necrotic tissue
  • active infection at the fistula site
  • severely scarred skin
  • deficient dartos around the fistula
  • fistulas more proximal to the mid penile position
  • recurrent fistulas
  • previous history of hypersensitivity to cyanoacrylate-based products

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Urology department - ain shams university

Cairo, 11361, Egypt

Location

MeSH Terms

Conditions

Hypospadias

Interventions

Bucrylate

Condition Hierarchy (Ancestors)

Urogenital AbnormalitiesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesPenile DiseasesGenital Diseases, MaleGenital DiseasesMale Urogenital DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Intervention Hierarchy (Ancestors)

CyanoacrylatesAcrylatesAcids, AcyclicCarboxylic AcidsOrganic ChemicalsNitrilesEnbucrilatePolymersMacromolecular SubstancesBiomedical and Dental MaterialsTissue AdhesivesManufactured MaterialsTechnology, Industry, and Agriculture

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
patients and their relatives were blinded to the type of the intervention
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Cases of group (I) underwent multilayered closure using dartos facial flap and cyanoacrylate glue as an interposition layer. Cases of the control group (II) underwent the same procedure without using cyanoacrylate.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistant lecturer

Study Record Dates

First Submitted

April 29, 2021

First Posted

May 7, 2021

Study Start

January 1, 2017

Primary Completion

January 1, 2020

Study Completion

January 1, 2020

Last Updated

May 7, 2021

Record last verified: 2021-05

Locations